$160.00
Tesamorelin is a synthetic analog of growth hormone–releasing hormone (GHRH). In research settings, it is studied for its ability to stimulate the anterior pituitary to release growth hormone, which in turn increases circulating levels of insulin-like growth factor-1 (IGF-1). These pathways are of interest for their roles in metabolic regulation and cellular growth processes.
Tesamorelin has been widely examined in clinical research related to body-fat distribution, particularly the mechanisms involved in visceral adipose tissue accumulation and breakdown. Studies show that Tesamorelin can influence metabolic signaling pathways associated with lipolysis and fat mobilization, making it a valuable tool for investigating the biology of visceral fat and related metabolic conditions.
The peptide is supplied as a lyophilized powder to support maximum stability during storage and handling.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Not for human consumption
